Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors (NCT04103346) | Clinical Trial Compass
CompletedNot Applicable
Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors
United States52 participantsStarted 2020-02-24
Plain-language summary
Exposure to fine particulate matter (PM2.5) air pollution is an established risk factor for cardiovascular (CV) morbidity.
Who can participate
Age range60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Nonsmoker
* ≥60 years old
* residing in Carpenter Place Apartments
Exclusion Criteria:
* Active cigarette smoker
* daily secondhand smoke exposure (self-report)
* any CV event (myocardial infarction, stroke, heart failure, revascularization) in the past 3 months
* unstable CV condition or risk factor (uncontrolled diabetes, class 3-4 angina or heart failure) or any medical condition that would place the participant at risk from participation or jeopardize study integrity (per investigators)
* expected overnight travel outside their apartment during the 14-week study period
* unable to provide informed consent
* lung disease requiring oxygen
* renal dialysis
* cancer receiving active treatment or chemotherapy
* severe uncontrolled high BP ≥160/100 mm Hg or SBP\<115 mm Hg.
* CV medication change in the prior month. If participants are on medications for high BP, diabetes, or a CV condition, they will need to have stable therapy during the prior month with no planned changes during the study period.